Review Article | Published:

Effects of psychological stress on male fertility

Nature Reviews Urology volume 12, pages 373382 (2015) | Download Citation

Abstract

Psychological stress can be defined as any uncomfortable 'emotional experience' accompanied by predictable biochemical, physiological and behavioural changes or responses. Many clinical studies looking at the effects of psychological stress on male fertility have shown that stress is associated with reduced paternity and abnormal semen parameters. Enough scientific evidence exists to suggest that psychological stress could severely affect spermatogenesis, mainly as a result of varying testosterone secretion. The hypothalamic–pituitary–adrenal axis has a direct inhibitory action on the hypothalamic–pituitary–gonadal (HPG) axis and Leydig cells in the testes. The newly discovered hormone, gonadotropin-inhibitory hormone (GnIH), also has an inhibitory effect on the HPG axis. Inhibition of the HPG axis results in a fall in testosterone levels, which causes changes in Sertoli cells and the blood–testis barrier, leading to the arrest of spermatogenesis. Germ cells also become vulnerable to gonadotoxins and oxidation. However, the extent and severity of the effects of psychological stress on human testes is difficult to study and data mostly come from animal models. Despite this limitation, stress as a causative factor in male infertility cannot be ignored and patients should be made aware of its effects on testicular function and fertility and helped to manage them.

Key points

  • Psychological stress has been perceived clinically as a potential risk factor for male infertility, although to what extent it affects human male fertility is difficult to study and evaluate

  • Clinical studies demonstrate an inverse relationship between psychological stress and semen parameters

  • The paraventricular nucleus (PVN) in the hypothalamus regulates stress responses and activates the sympathetic–adrenal system (SAS), and the hypothalamic–pituitary–gonadal (HPG) and hypothalamic–pituitary–adrenal (HPA) axes

  • Activation of HPG and HPA axes leads to a fall in testosterone levels in the testes, affecting Sertoli cells and the blood—testis barrier

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Neural control of stress adaptation. Front. Behav. Neurosci. (2013).

  2. 2.

    Stress and disorders of the stress system. Nat. Rev. Endocrinol. 5, 374–381 (2009).

  3. 3.

    , & Stress and Health: Psychological, behavioral and biological determinants. Annu. Rev. Clin. Psychol. 1, 607–628 (2005).

  4. 4.

    & Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol. Reprod. 49, 523–532 (1991).

  5. 5.

    Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87, 873–904 (2007).

  6. 6.

    & Reproduction and resistance to stress when and how. J. Neuroendocrinol. 15, 711–724 (2003).

  7. 7.

    & Health psychology: mapping biobehavioral contributions to health and illness. Ann. Rev. Psychol. 50, 137–163 (1999).

  8. 8.

    , & The role of sex steroids in the pathogenesis and maintenance of benign prostatic hyperplasia. Mt Sina. J. Med. 64, 20–25 (1997)

  9. 9.

    Estrogen regulation of testicular function. Reprod. Biol. Endocrinol. 27, 51 (2005)

  10. 10.

    et al. Effect of psychological stress on the L-arginine-nitric oxide pathway and semen quality. Braz. J. Med. Biol. Res. 39, 581–588 (2006).

  11. 11.

    Variation of semen parameters in healthy medical students due to exam stress. Malawi Med. J. 21, 166–167 (2009).

  12. 12.

    , , & Effect of the Lebanese civil war on sperm parameters. Fertil. Steril. 88, 1579–1582 (2007).

  13. 13.

    , , & Decline in sex ratio at birth after 10-day war in Slovenia. Hum. Reprod. 17, 3173–3177 (2002).

  14. 14.

    , , , & Semen characteristics of Vietnam veterans. Reprod. Toxicol. 3, 165–173 (1989).

  15. 15.

    , , , & The effect of stress on the semen quality [Polish]. Med. Pr. 61, 607–613 (2010).

  16. 16.

    et al. Effect of psychological stress on human semen quality. J. Androl. 18, 194–202 (1997).

  17. 17.

    , , , & Job strain and male fertility. Epidemiology 15, 21–27 (2004).

  18. 18.

    & Does stress affect male infertility?—a debate. Med. Sci. Monit. 11, SR11–SR13 (2005)

  19. 19.

    , & Neural circuits mediating stress. Biol. Psychiatry 46, 1461–1471 (1999).

  20. 20.

    The limbic system: An outline and brief history of its concept. Neuropathology 18, 211–214 (1998).

  21. 21.

    Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin. Neurosci. 8, 367–381 (2006).

  22. 22.

    Stressor-specific activation of the hypothalamic-pituitary-adrenocortical axis. Physiol. Res. 49 (Suppl. 1), S11–S17 (2000).

  23. 23.

    , & The paraventricular nucleus of the hypothalamus, a potential target for integrative treatment of autonomic dysfunction. Expert Opin. Ther. Targets 12, 717–727 (2008).

  24. 24.

    et al. Corticotropin releasing hormone, stress and human reproduction: an update. J. Reprod. Med. 85, 33–39 (2010).

  25. 25.

    , , , & Review: Stress, neurotransmitters, corticosterone and body–brain integration. Brain Res. 1476, 71–85 (2012).

  26. 26.

    , & Neuroendocrinology of stress. Endocrinol. Metabol. Clin. North Am. 30, 695–728 (2001).

  27. 27.

    & Chronic stress, visceral obesity and gonadal dysfunction. Hormones 7, 287–293 (2008).

  28. 28.

    et al. Role of paraventricular nucleus-projecting norepinephrine/epinephrine neurons in acute and chronic stress. Eur. J. Neurosci. 39, 1903–1911 (2014).

  29. 29.

    & Participation of alpha 1-adrenergic receptors in the secretion of hypothalamic corticotropin releasing hormone during stress. Neuroendocrinology 56, 153–160 (1992).

  30. 30.

    , , & Catecholamine effects upon rat hypothalamic corticotropin–releasing hormone secretion in vitro. J. Clin. Invest. 82, 839–846 (1988).

  31. 31.

    , & Endocrinology of stress response. Annu. Rev. Physiol. 67, 259–284 (2005).

  32. 32.

    in Pediatric Endocrinology 2nd edn Ch. 1 (ed. Sperling, M. A.) 1–14 (Saunders, 2002).

  33. 33.

    et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat. Med. 13, 803–811 (2007).

  34. 34.

    & Recent advances in basic science: Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut 54, 1481–1491 (2005).

  35. 35.

    & Proopiomelanocortin processing in the pituitary, central nervous system and peripheral tissues. Endocr. Rev. 9, 159–179 (1988).

  36. 36.

    , & Stress and nerve growth factor: findings in animal models and humans. Pharmacol. Biochem. Behav. 73, 159–166 (2002).

  37. 37.

    , & If it is up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol. Bull. 133, 25–45 (2007).

  38. 38.

    , & Chronic stress and sympathetic-adrenal medullary responsiveness. Soc. Sci. Med. 26, 333–341 (1988).

  39. 39.

    , & Habituation of sympathetic-adrenal medullary responses following exposure to chronic intermittent stress. Physiol. Behav. 45, 255–261 (1989).

  40. 40.

    , & Control and intrusive memories as possible determinants of chronic stress. Psychosom. Med. 55, 274–286 (1993).

  41. 41.

    & In Measuring stress: A guide for health and social scientists Ch. 8 (eds Cohen, S., Kessler, R. C. & Underwood, L. G.), 193–212 (Oxford University Press, 1995).

  42. 42.

    , & A stochastic differential equation model of diurnal cortisol patterns. Am. J. Physiol. Endocrinol. Metab. 280, E450–E461 (2001).

  43. 43.

    & The need to belong: Desire for interpersonal attachments as a fundamental human motivation. Psychol. Bull. 117, 497–529 (1995).

  44. 44.

    Hypothalamus-Pituitary-Gonadal axis: It is time for revision. Human Genet. Embryol. (2012).

  45. 45.

    , , , & Stress increases putative gonadotropin inhibitory hormone and decreases luteinising hormone in male rats. Proc. Natl. Acad. Sci. USA 106, 11324–11329 (2009).

  46. 46.

    Opioid peptides. Alcohol Health Res. World 21, 132–136 (1997).

  47. 47.

    et al. Role of endogenous opioid system in the regulation of the stress response. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 729–741 (2001).

  48. 48.

    , , , & Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion. Am. J. Obstet. Gynecol. 152, 485–493 (1985).

  49. 49.

    , , & Narrative Review: The Role of Leptin in Human Physiology: Emerging Clinical Applications. Ann. Intern. Med. 152, 93–100 (2010).

  50. 50.

    , & leptin's actions on the reproductive axis: perspectives and mechanisms. Biol. Reprod. 60, 216–222 (1999).

  51. 51.

    et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250–252 (1996).

  52. 52.

    , & Functional relationship between obesity and male reproduction: from humans to animal models. Hum. Reprod. Update 17, 667–683 (2011).

  53. 53.

    et al. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 138, 3859–3863 (1997).

  54. 54.

    & GnRH-induced Ca2+ signaling patterns and gonadotropin secretion in pituitary gonadotrophs. Functional adaptations to both ordinary and extraordinary physiological demands. Front. Endocrinol. (Lausanne) (2013).

  55. 55.

    & Deploarising and hyperpolarising actions of GABA (A) receptor activation on gonadotrophin-releasing hormone neurones: towards an emerging consensus. J. Neuroendocrinol. 23, 557–569 (2011).

  56. 56.

    & Update on male hormonal contraception: Is the vasectomy in jeopardy? Int. J. Impot Res. 22, 159–170 (2010).

  57. 57.

    , , & Role of estrogen receptors and G protein-coupled estrogen receptor in regulation of hypothalamus-pituitary-testis axis and spermatogenesis. Front. Endocrinol. (Lausanne) (2014).

  58. 58.

    et al. Luteinizing hormone pulsatility in subjects with 5-alpha-reductase deficiency and decreased dihydrotestosterone production. J. Clin. Endocrinol. Metab. 78, 916–921 (1994).

  59. 59.

    , , , & Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J. Clin. Endocrinol. Metabol. 86, 53–58 (2001).

  60. 60.

    , , , & Genomic and nongenomic cross talk between the gonadotropin-releasing hormone receptor and glucocorticoid receptor signaling pathways. Mol. Endocrinol. 23, 1726–1745 (2009).

  61. 61.

    et al. Rapid mechanisms of glucocorticoid signaling in the Leydig cell. Steroids 73, 1018–1024 (2008).

  62. 62.

    & The regulation of spermatogenesis by androgens. Semin. Cell Dev. Biol. 30, 2–13 (2014).

  63. 63.

    , & Common medications and drugs: how they affect male fertility. Urol. Clin. North Am. 29, 965–973 (2002).

  64. 64.

    & The decline of androgen levels in elderly men and its therapeutic implications. Endocr. Rev. 26, 833–876 (2005).

  65. 65.

    , & Role of estrogens in spermatogenesis. Front. Biosci. (Elite Ed.) 4, 1–11 (2012).

  66. 66.

    Synthesis and regulation of sex hormone-binding globulin in obesity. Int. J. Obes. Relat. Metab. Disord. 24 (Suppl. 2), S64–S70 (2000).

  67. 67.

    & Steroid 5 alpha-reductase: two genes/two enzymes. Ann. Rev. Biochem. 63, 25–61 (1994).

  68. 68.

    et al. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men. J. Clin. Endocrinol. Metab. 92, 1659–1665 (2007).

  69. 69.

    , & The androgen 5α-dihydrotestosterone and its metabolite 5α-dndrostan-3β, 17β-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor β-expressing neurons in the hypothalamus. J. Neurosci. 26, 1448–1456 (2006).

  70. 70.

    , , , & Research Report: Central 5-alphareduction oftestosterone is required for testosterone's inhibition of the hypothalamo- pituitary–adrenal axis response to restraint stress in adult male rats. Brain Res. 1529, 74–82 (2013).

  71. 71.

    , , & DHEA and its transformation into androgens and estrogens in peripheral tissues: intrcrinology. Front. Neuroendocrinol. 22, 185–212 (2005).

  72. 72.

    , , , & neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 30, 65–91 (2009).

  73. 73.

    , , , & DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39, 327–348 (1999).

  74. 74.

    , , , & Effects of prolonged stress on salivary cortisol and dehydroepiandrosterone: a study of a two-week teaching practice. Psychoneuroendocrinology 37, 852–858 (2012).

  75. 75.

    et al. Decline in dehydroepiandrosterone sulphate observed in chronic urticarial is associated with psychological distress. Psychsom. Med. 70, 723–728 (2008).

  76. 76.

    , , & Kisspeptin increases GnRH mRNA expression and secretion in GnRH secreting neuronal cell lines. Mol. Cell Endocrinol. 311, 126–134 (2009).

  77. 77.

    , , , & Distribution of kisspeptin neurons in the adult female mouse brain. J. Neuroendocrinol. 21, 673–682 (2009).

  78. 78.

    & Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 25, 150–176 (2004).

  79. 79.

    , & Effects of kisspeptin on parameters of HPA axis. Endocrine 39, 220–228 (2011).

  80. 80.

    & The effects of kisspeptin in human reproductive function—therapeutic implications. Curr. Drug Targets. 14, 365–371 (2013).

  81. 81.

    et al. Glucocorticoids inhibit kisspeptin neurons during stress-induced reproductive inhibition. Endocr. Rev. 32 (Meeting Abstracts), P3–P141 (2011).

  82. 82.

    & The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinol. Metab. Clin. North Am. 31, 63–78 (2002).

  83. 83.

    et al. Glucocorticoid receptor-mediated repression of gonadotropin-releasing hormone promoter activity in GT1 hypothalamic cell lines. Endocrinology 134, 1467–1474 (1994).

  84. 84.

    & Glucocorticoids, Stress, and Fertility. Minerva Endocrinol. 35, 109–125 (2010).

  85. 85.

    et al. Localization of the glucocorticoid receptor in testis and accessory sexual organs of male rat. Mol. Cell Endocrinol. 95, 115–120 (1993).

  86. 86.

    , & Production rates of testosterone in patients with Cushing's syndrome. Metabolism 49, 229–231 (2000).

  87. 87.

    & Multiple mechanisms for regulation of 3b-hydroxysteroid dehydrogenase/D5–D4-isomerase, 17a-hydroxylase/C17–20 lyase cytochrome P450, and cholesterol side-chain cleavage cytochrome P450 messenger ribonucleic acid levels in primary cultures of mouse Leydig cells. Endocrinology 129, 1429–1435 (1991).

  88. 88.

    et al. A novel avian hypothalamic peptide inhibiting gonadotropin release. Biochem. Biophys. Res. Commun. 275, 661–667 (2000).

  89. 89.

    , & Review: evolution of GnIH and related peptides structure and function in the chordates. Front. Neurosci. (2014).

  90. 90.

    et al. Central and direct regulation of testicular activity by gonadotropin-inhibitory hormone and its receptor. Front. Endocrinol. (Lausanne) (2014).

  91. 91.

    et al. New neuropeptides containg carboxy-terminal RFamide and their receptor in mammals. Nat. Cell Biol. 2, 703–708 (2000).

  92. 92.

    et al. Identification and Characterization of two G.-protein coupled receptors for neuropeptide FF. J. Biol. Chem. 275, 3924–3931 (2000).

  93. 93.

    , , & Gonadotropin-inhibitory hormone (GnIH) secretion into the ovine hypophseal portal system. Endocrinology 153, 3368–3375 (2012).

  94. 94.

    et al. Melatonin stimulates the release of gonadotropin inhibitory hormone by the avian hypothalamus. Endocrinology 151, 271–280 (2010).

  95. 95.

    , , & Prolaction in man: a tale of two promoters. Bioassays 28, 1051–1056 (2006).

  96. 96.

    Prolactin and male fertility: the long and short feedback regulation. Int. J. Endocrinol. (2009).

  97. 97.

    , , , & Growth hormone, prolactin and sexuality. J. Endocrinol. Invest. 35, 782–794 (2012).

  98. 98.

    & Reproductive role of prolactin. Reproduction 133, 361–369 (2007).

  99. 99.

    Hyperprolactinaemia and infertility: New insights. J. Clin. Invest. 122, 3467–3468 (2012).

  100. 100.

    , & Severe hyperprolactinemia directly depresses the gonadal activity causing infertility. Esculapio J. Services Inst. Med. Sci. 2, 25–27 (2007).

  101. 101.

    , & Burnout is associated with elevated prolactin levels in men but not in women. J. Psychosom. Res. 76, 380–383 (2014).

  102. 102.

    & Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology 36, 1530–1539 (2011).

  103. 103.

    Review: Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes? Br. J. Sports Med. 37, 100–105 (2003).

  104. 104.

    et al. Relaxin family peptides and their receptors. Physiol. Rev. 93, 405–480 (2013).

  105. 105.

    & Modulation of growth hormone action by sex steroids. Clin. Endocrinol. (Oxf.) 65, 413–422 (2006).

  106. 106.

    , & The emerging role of insulin-like growth factors in testis development and function. Basic Clin. Androl. 24, (2014).

  107. 107.

    et al. Insulin-like growth factor-I (IGF-I) and IGF-I receptor in human testis: an immunohistochemical study. Fertil. Steril. 49, 666–669 (1988).

  108. 108.

    & Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 53, 865–871 (2002).

  109. 109.

    in Handbook of Neuroendocrinology. Ch. 8 (eds Fink, G., Pfaff, D. W. & Levine, E.) 175–196 (Academic Press, 2011).

  110. 110.

    , & The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. QJM 93, 323–333 (2000).

  111. 111.

    , , & The effect of nitric-oxide-related supplements on human performance. Sports Med. 42, 99–117 (2012).

  112. 112.

    et al. human sperm tail proteome suggests new endogenous metabolic pathways. Mol. Cell Proteomics 12, 330–342 (2013).

  113. 113.

    et al. Production of nitric oxide and peroxynitrite by human spermatozoa and their possible role on sperm motility. Endocrine Abstracts 29, P1055 (2012).

  114. 114.

    & Psychological factors associated with male sexual dysfunction: screening and treatment for the urologist. Urol. Clin. North Am. 38, 141–146 (2011).

  115. 115.

    et al. Sexual dysfunctions induced by stress of timed intercourse and medical treatment. BJU Int. 111, 227–234 (2013).

  116. 116.

    et al. Stress affects a gastrin-releasing peptide system in the spinal cord that mediates sexual function: implications for psychogenic erectile dysfunction. PLoS ONE (2009).

  117. 117.

    et al. Prevalence and correlates of prostatitis in the health professionals follow up study cohort. J. Urol. 167, 1363–1366 (2002).

  118. 118.

    & Mechanisms in prostatitis/chronic pelvic pain syndrome. J. Urol. 172, 839–845 (2004).

  119. 119.

    , , , & Impact of infection on the secretory capacity of male accessory glands. Int. Braz. J. Urol. 35, 299–308 (2009).

  120. 120.

    , , & Reduced semen quality caused by chronic abacterial prostatitis: an enigma or reality? Fertil. Steril. 61, 1109–1116 (1994).

  121. 121.

    , , & Morphological sperm alterations in different types of prostatitis. Andrologia 35, 288–293 (2003).

  122. 122.

    et al. Seminal oxidative stress in patients with chronic prostatitis. Urology 55, 881–885 (2000).

  123. 123.

    , & Tuberculous epididymo-orchitis and prostatitis: a case report. Andrologia 40, 81–83 (2008).

Download references

Author information

Affiliations

  1. Department of Urology, Homerton University Hospital, Homerton Row, London E9 6SR, UK.

    • Vinod H. Nargund

Authors

  1. Search for Vinod H. Nargund in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Vinod H. Nargund.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrurol.2015.112

Further reading